February 2021 - Evolution Biotechnologies
0
archive,date,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-16.4,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Japanese Patent Office announces its intention to grant Evolution  Biotechnologies Application No. 2018-525822, “Acaricidals” Bedford, UK, February 1st 2021 Evolution Biotechnologies (www.evolutionbiotech.com), the UK based company pioneering the use of biological control to benefit human health, today announced that it has been notified  by the Japan Patent Office of their intention to grant Patent Application No. 2018-525822,  “Acaricidals”, deriving from WO2017025732A1 “Acaricides”, This will provide broad  protection for both formulation and use of Evolution’s biological control technology for house  dust mites in the control of asthma and other allergic diseases. As a result of this award, Evolution will now have exclusive...